0001209191-20-003104.txt : 20200110 0001209191-20-003104.hdr.sgml : 20200110 20200110180201 ACCESSION NUMBER: 0001209191-20-003104 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200108 FILED AS OF DATE: 20200110 DATE AS OF CHANGE: 20200110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LASEZKAY GEORGE M CENTRAL INDEX KEY: 0001020514 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37783 FILM NUMBER: 20522115 MAIL ADDRESS: STREET 1: 1301 SECOND AVE., SUITE 4200 CITY: SEATTLE STATE: WA ZIP: 98101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clearside Biomedical, Inc. CENTRAL INDEX KEY: 0001539029 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452437375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 NORTH POINT PARKWAY STREET 2: SUITE 200 CITY: ALPHARETTA STATE: 2Q ZIP: 30005 BUSINESS PHONE: 678-270-3631 MAIL ADDRESS: STREET 1: 900 NORTH POINT PARKWAY STREET 2: SUITE 200 CITY: ALPHARETTA STATE: 2Q ZIP: 30005 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-01-08 0 0001539029 Clearside Biomedical, Inc. CLSD 0001020514 LASEZKAY GEORGE M C/O CLEARSIDE BIOMEDICAL, INC. 900 NORTH POINT PARKWAY, SUITE 200 ALPHARETTA GA 30005 1 1 0 0 CEO Common Stock 2020-01-08 4 A 0 66250 0.00 A 288250 D Stock Option (Right to Buy) 2.37 2020-01-08 4 A 0 198750 0.00 A 2030-01-08 Common Stock 198750 198750 D These shares are represented by restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock of the Issuer. The shares underlying the RSU vest in 4 equal annual installments on each of January 8, 2021, January 8, 2022, January 8, 2023 and January 8, 2024, subject to the Reporting Person's continuous service as of each such vesting date, and subject to accelerated vesting in specified circumstances. One-fourth of the shares underlying this option vest on January 8, 2021 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date. /s/ Mark Ballantyne, Attorney-in-Fact 2020-01-10